MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,364,000 | +742.0% | 25,987 | +133.6% | 0.01% | +900.0% |
Q1 2019 | $162,000 | +28.6% | 11,125 | -2.3% | 0.00% | 0.0% |
Q4 2018 | $126,000 | -88.0% | 11,390 | -71.4% | 0.00% | -85.7% |
Q3 2018 | $1,048,000 | +49.3% | 39,837 | +16.0% | 0.01% | +40.0% |
Q2 2018 | $702,000 | -68.0% | 34,354 | -71.5% | 0.01% | 0.0% |
Q1 2018 | $2,191,000 | +37.4% | 120,599 | +5.4% | 0.01% | +25.0% |
Q4 2017 | $1,595,000 | +88.3% | 114,389 | +150.5% | 0.00% | +100.0% |
Q3 2017 | $847,000 | +17.5% | 45,659 | +6.8% | 0.00% | 0.0% |
Q2 2017 | $721,000 | +19.8% | 42,739 | -5.0% | 0.00% | 0.0% |
Q1 2017 | $602,000 | -19.8% | 45,011 | -9.8% | 0.00% | 0.0% |
Q4 2016 | $751,000 | -58.8% | 49,900 | -74.7% | 0.00% | -66.7% |
Q1 2016 | $1,825,000 | -44.1% | 197,517 | -10.2% | 0.01% | -40.0% |
Q4 2015 | $3,265,000 | +106.0% | 220,032 | +127.8% | 0.01% | +100.0% |
Q3 2015 | $1,585,000 | -27.1% | 96,573 | -49.6% | 0.01% | 0.0% |
Q3 2014 | $2,173,000 | +6.4% | 191,633 | +13.4% | 0.01% | 0.0% |
Q2 2014 | $2,042,000 | -12.2% | 169,023 | -15.4% | 0.01% | -28.6% |
Q1 2014 | $2,326,000 | -17.1% | 199,674 | +25.9% | 0.01% | -22.2% |
Q4 2013 | $2,805,000 | – | 158,638 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |